Crown Bioscience Inc.
CrownBio Enters Partnership with Pierre Fabre to Accelerate Discovery and Development of Immuno-Oncology Agents
SAN DIEGO, June 19, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces that it has been selected by Pierre Fabre Research Institute as one of their partners to advance their immuno-oncology drug discovery pipeline.
CrownBio boasts the world's largest collection of patient-derived xenograft (PDX) models and is a leading provider of humanized solutions for immuno-oncology drug development. Leveraging these exclusive capabilities, CrownBio will engraft PDX models selected by Pierre Fabre into CD34+ humanized mouse models. These customized, humanized models will be used to accelerate Pierre Fabre's innovative immuno-oncology drug discovery pipeline.
"Pierre Fabre recognizes the value of CrownBio's extensive PDX collection and their expertise in implementing innovative humanization strategies," said Nathalie Corvaia, Pierre Fabre's Head of New Biologic Entity Platform and Director of Center of Immunology R&D Pierre Fabre. "We have chosen them as our partner for these reasons and look forward to what we are confident will be a successful alliance."
"We are very pleased that Pierre Fabre has selected us as a trusted partner to advance their cutting-edge immuno-oncology pipeline," said Jean-Pierre Wery, CrownBio's CEO. "Our unique capabilities will enable Pierre Fabre to continue providing new and improved therapies for the treatment of cancer."
About Crown Bioscience Inc.
CrownBio is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, CrownBio enables clients to deliver superior clinical candidates.
Crown Bioscience Inc.
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
Mohawk Industries, Inc.25.4.2019 22:16:38 CEST | Pressemeddelelse
Mohawk Industries Reports Q1 Results
BGRS; Relo Group, Inc.25.4.2019 17:57:12 CEST | Pressemeddelelse
BGRS Acquired by Relo Group, Inc.
Ascom Holding AG25.4.2019 14:02:07 CEST | Pressemeddelelse
Ascom adds ‘talk before walk’ wireless speech function to new release of Ascom teleCARE IP
Bombardier Inc.25.4.2019 12:01:30 CEST | Pressemeddelelse
Bombardier Provides Preliminary First Quarter 2019 Financial Results, Updates 2019 Guidance
Magna International Inc.24.4.2019 19:56:51 CEST | Pressemeddelelse
First Quarter 2019 Results Conference Call
Juniper Networks24.4.2019 09:01:39 CEST | Pressemeddelelse
Colruyt Group Selects Juniper Networks to Support its Digital Transformation
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum